Predictors of pandemic (H1N1) 2009 virus positivity and adverse outcomes among hospitalized patients with a compatible syndrome

Israel Medical Association Journal

Volumn 12, Issue 10, 2010, Pages 622-627

  Shlomai, Amir ^a   Nutman, Amir ^a   Kotlovsky, Taly ^a   Schechner, Vered ^a   Carmeli, Yehuda ^a   Guzner Gur, Hanan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Intensive care unit; Mortality; Pandemic (H1N1) 2009 virus; Prognosis

Indexed keywords

OSELTAMIVIR;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COUGHING; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; FLU LIKE SYNDROME; HOSPITAL PATIENT; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYALGIA; PANDEMIC INFLUENZA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ISRAEL; MALE; MIDDLE AGED; PANDEMICS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 78449234740     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460: 1021-5.
2. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459: 931-9.
3. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361: 674-9.
4. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-9.
5. Pandemic alert level 6: scientific criteria for an influenza pandemic fulfilled. Euro Surveill 2009; 14: 19237.
6. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009: 361(20): 1935-44.
7. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302: 1872-9.
8. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302: 1896-902.
9. Senanayake SN. Swine flu update: bringing home the bacon. Med J Aust 2009; 191: 138-40.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
11. Michaelis M, Doerr H, Cinatl J. Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol 2009; 198: 175-83.
12. Szyper-Kravitz M. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. IMAJ Isr Med Assoc J 2009; 11: 633-4.
13. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000; 74: 6105-16.
14. Monto AS. The risk of seasonal and pandemic influenza: prospects for control. Clin Infect Dis 2009; 48(Suppl 1): S20-5.
15. Ikonen N, Strengell M, Kinnunen L, et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 2010;15.